Crossmark

Cardiovascular toxicities of systemic treatments of prostate cancer

Crossref DOI link: https://doi.org/10.1038/nrurol.2016.273

Published Online: 2017-01-24

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Veccia, Antonello

Maines, Francesca

Kinspergher, Stefania

Galligioni, Enzo

Caffo, Orazio
License Information

Text and Data Mining valid from 2017-01-24
More Information

Article History

First Online: 24 January 2017

Competing interests

: O.C. has received honoraria from, Astellas, Janssen and Sanofi Aventis. The other authors declare no competing interests.